GSK plc (NYSE:GSK) confirmed the sale of 385.3 million shares in Haleon plc (NYSE:HLN) for $1.58 billion. The shares represented around 4.2% of the issued share capital of Haleon. Following the ...
LONDON - Days after carving out its consumer health business, a slimmed down GSK delivered a strong second-quarter ...
LONDON -Pfizer plans to sell its 32% stake in Haleon, its consumer health venture with British drugmaker GSK, after the ...
Tuesday, GSK plc (NYSE:GSK) announced to sell 300 million ordinary shares in Haleon plc (NYSE:HLN) at 326 pence per share, raising gross proceeds of approximately £978 million. Following the ...
A Reuters report regarding the rejection of Unilever's $68 billion offer for GlaxoSmithKline’s consumer healthcare assets is raising questions, including whether Unilever should raise the bid and risk ...
LONDON (Reuters Breakingviews) - GlaxoSmithKline’s personal health spinoff is beginning life with a target on its back. Haleon, maker of Advil painkillers and Sensodyne toothpaste, will next month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results